- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07293650
MÉDecine de PRÉcision dans l'Achalasie (PREMEDIA) (PREMEDIA)
MÉDecine de PRÉcision Dans l'Achalasie - Un Essai Clinique Multicentrique Randomisé de Non-Infériorité de POEM Court Personnalisé vs. POEM Standard pour l'Achalasie Non-Spastique et Une Étude de Cohorte Prospective Multicentrique de POEM Long Personnalisé pour les Troubles de la Motricité Œsophagienne Spastiques
The goal of this clinical trial is to learn if shorter Per-Oral Endoscopic Myotomy (POEM) works as well as a longer POEM in patients with trouble swallowing due to certain conditions. The main question[s] it aims to answer [is/are]:
- Does making a smaller cut in the muscle at the bottom of the esophagus work just as well as making the standard bigger cut in relieving symptoms?
- Does making the smaller cut reduce the side effects of the procedure compared to the standard bigger cut? Researchers will compare the symptoms and side effects of making a shorter cut to the symptoms and side effects of a longer cut.
Participants will allow researchers to access their standard of care information in their medical record, complete questionnaires at up to 6 times over a 2-year period.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
The investigators will perform a randomized controlled trial to compare two different approaches to Peroral Endoscopic Myotomy (POEM) for treating achalasia (Types I and II) and esophagogastric junction outflow obstruction (EGJOO). The most widely used treatment for achalasia is POEM but the current approach involves a 9 cm (3.5 inch) myotomy (cutting of the muscle) to open up the tight lower esophageal sphincter to promote food delivery from the esophagus to the stomach. This approach is very effective, with success rates of approximately 90% over the short term. However, the investigators believe that POEM does not require a full 9 cm myotomy and that the investigators can cut much less muscle (approximately 4cm/1.25inches) to achieve similar improvement in symptoms but with less long-term complications. Cutting less muscle may result in less acid reflux, which is the Achilles heel of any successful treatment for achalasia. A shorter muscle cut may also result in less of a complication known as blown-out myotomy, which causes failure of the esophagus to empty its contents and is a major cause of long-term symptom relapse. The investigators have designed this study to determine whether the shorter myotomy (4 cm) is equivalent to the longer myotomy (9 cm) in terms if symptom improvement, but with the possibility of less acid reflux and blown-out myotomy.
Given these questions, the investigators will enroll 370 patients in a randomized trial where patients will receive either the short tailored (4cm/1.25 inches) or the standard myotomy (9cm/3.5 inches). All patients will undergo intraoperative assessment of success of the myotomy by using a special tool called the functional lumen imaging probe (FLIP). The FLIP will measure the opening dimensions of the lower esophageal sphincter and ensure that the myotomy is adequately performed so that the lower esophageal sphincter can open to a level that will improve esophageal emptying/swallowing. The investigators will follow patients for 2 years in a manner similar to how the investigators would follow patients after achalasia treatment in standard clinical practice. The investigators will assess whether symptoms are similar and whether or not there are differences in acid reflux and esophageal emptying. Patients will undergo follow up testing with questionnaires at intervals of 3-6 months over two years and they will have reflux testing (measure acid exposure using a capsule placed during endoscopy) between 6-12 months and a barium esophagram (X ray while drinking barium) at 2 years. The most important aim is to prove that the symptoms and outcomes success/failure) between the two approaches are similar (short myotomy is non-inferior) and the Eckardt score will be the primary questionnaire score for this study. The investigators believe that this study will help define the optimal approach to POEM in achalasia and also help us prevent complications in the future.
Additionally, the investigators will also ask participants to provide a sample of the muscle tissue that is typically cut during the POEM. This tissue will help us develop a tissue bank to help other researchers looking into the causes of why achalasia and these other esophageal diseases occur. The participants can opt out of this part and still continue in the randomized controlled trial.
Type d'étude
Inscription (Estimé)
Phase
- Phase 3
Contacts et emplacements
Coordonnées de l'étude
- Nom: Elizabeth Yan, BS
- Numéro de téléphone: 312-908-1723
- E-mail: premedia.dcc@northwestern.edu
Sauvegarde des contacts de l'étude
- Nom: Yasmin Pina, BS
- Numéro de téléphone: 312-503-6459
- E-mail: premedia.dcc@northwestern.edu
Lieux d'étude
-
-
Arizona
-
Scottsdale, Arizona, États-Unis, 85259
- Pas encore de recrutement
- Mayo Clinic Arizona
-
-
California
-
La Jolla, California, États-Unis, 92037
- Recrutement
- University of California San Diego
-
Chercheur principal:
- Rena Yadlapati, MD
-
Contact:
- Alexander Gonsalves, Lead Study Coordinator
- Numéro de téléphone: 858-246-5236
- E-mail: PREMEDIA@health.ucsd.edu
-
-
Colorado
-
Denver, Colorado, États-Unis, 80217
- Pas encore de recrutement
- University of Colorado Denver
-
-
Florida
-
Gainesville, Florida, États-Unis, 32611
- Recrutement
- University of Florida
-
Chercheur principal:
- Peter Draganov, MD
-
Contact:
- April Goddard, Lead Study Coordinator, PA-C
- Numéro de téléphone: 352-273-9483
- E-mail: DOM-GIResereachTeam@ad.ufl.edu
-
Orlando, Florida, États-Unis, 32803
- Pas encore de recrutement
- Adventist Health System/Sunbelt, Inc
-
-
Georgia
-
Atlanta, Georgia, États-Unis, 30322
- Recrutement
- Emory University
-
Chercheur principal:
- Anand Jain, MD
-
Contact:
- Halley Fowler, Lead Study Coordinator
- Numéro de téléphone: 404-778-3184
- E-mail: halley.fowler@emory.edu
-
-
Illinois
-
Chicago, Illinois, États-Unis, 60611
- Recrutement
- Northwestern University
-
Chercheur principal:
- John Pandolfino, MD
-
Contact:
- Eric Pfannkuche, Lead Study Coordinator
- Numéro de téléphone: 312-926-4525
- E-mail: PREMEDIA@northwestern.edu
-
-
Maryland
-
Baltimore, Maryland, États-Unis, 21218
- Pas encore de recrutement
- Johns Hopkins University
-
-
Massachusetts
-
Boston, Massachusetts, États-Unis, 02114
- Recrutement
- Massachusetts General Hospital
-
Contact:
- Madison Paylor, Lead Study Coordinator
- Numéro de téléphone: 617-726-0196
- E-mail: premedia@mgb.org
-
Chercheur principal:
- Kyle Staller, MD
-
-
Missouri
-
St Louis, Missouri, États-Unis, 63110
- Recrutement
- Washington University
-
Contact:
- Darren Nix, Lead Study Coordinator
- Numéro de téléphone: 314-273-1432
- E-mail: Premediasurgerytrial@wustl.edu
-
Chercheur principal:
- Chandra Gyawali, MD
-
-
New York
-
New York, New York, États-Unis, 10065
- Pas encore de recrutement
- Weill Cornell Medical College
-
-
North Carolina
-
Charlotte, North Carolina, États-Unis, 28204
- Recrutement
- Atrium Health/Wake Forest
-
Chercheur principal:
- Badih Elmunzer, MD
-
Contact:
- Greg Scarola, Lead Study Coordinator
- Numéro de téléphone: (704) 355-2000
- E-mail: PREMEDIA@advocatehealth.org
-
-
Ohio
-
Cleveland, Ohio, États-Unis, 44109
- Recrutement
- MetroHealth Medical Center
-
Chercheur principal:
- Ronnie Fass, MD
-
Contact:
- Stephanie Baker, Lead Study Coordinator
- Numéro de téléphone: 216-778-5736
- E-mail: premedia@metrohealth.org
-
Cleveland, Ohio, États-Unis, 44106
- Pas encore de recrutement
- Case Western Reserve University
-
-
Tennessee
-
Nashville, Tennessee, États-Unis, 37232
- Recrutement
- Vanderbilt University Medical Center
-
Chercheur principal:
- Dhyanesh Patel, MD
-
Contact:
- Larry Raber, Lead Study Coordinator
- Numéro de téléphone: 615-322-4643
- E-mail: larry.w.raber@vumc.org
-
-
Texas
-
Dallas, Texas, États-Unis, 75246
- Recrutement
- Baylor Scott & White Health
-
Contact:
- Neomy Flores, Lead Study Coordinator
- Numéro de téléphone: 214-820-9704
- E-mail: premedia@bswhealth.org
-
Chercheur principal:
- Vani Albertson Konda, MD
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria
- Age ≥ 18
- Type I achalasia or type II achalasia or cEGJOO
- Eckardt score > 3
Exclusion Criteria
The following exclusion criteria are for the RCT, but 1-13 below also pertain to the observational study:
- Prior POEM
- Prior surgical treatment for achalasia
- Endoscopic pneumatic dilation or lower esophageal sphincter botulinum toxin (botox) injection within 6 months
- Prior unrelated esophageal or upper gastric surgery, including Roux-en-Y gastric bypass and sleeve gastrectomy
- Prior endoscopic gastroesophageal intervention for obesity or GERD, such endoscopic sleeve gastroplasty or transoral incisionless fundoplication
- Known secondary achalasia related to malignancy (pseudoachalasia)
- Known eosinophilic esophagitis
- Diverticulum (> 2 cm) in distal esophagus
- Megaesophagus
- Fibroinflammatory stricture of the esophagus due to any etiology (e.g., peptic, radiation, eosinophilic)
- Pregnancy
- Standard contraindications to general anesthesia
- Standard contraindications to endoscopic myotomy in the esophagus (e.g. untreated varices)
- Unwillingness or inability to consent for the study
- Anticipated inability to follow protocol
- Weekly (or more frequent) opioid medication use in the last 2 years
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Quadruple
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Comparateur actif: Myotomie standard
|
Myotomy during POEM of 8-10 cm in length, extending 2-3 cm into the gastric cardia; intention to perform selective circular myotomy, but allowing full thickness myotomy. FLIP is used to confirm adequate myotomy. |
|
Expérimental: Myotomie courte personnalisée
|
Myotomy during POEM of 4-5 cm in length, extending 1-2 cm into the gastric cardia; intend to perform selective circular myotomy, but allowing full thickness myotomy. FLIP is used to confirm adequate myotomy. |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Clinical Response-Overall
Délai: From enrollment to Year 2
|
Clinical Response is defined by the Eckardt score (a 4-item self-report scale measuring weight loss, chest pain, regurgitation, and dysphagia) with no need for retreatment in 2 years. |
From enrollment to Year 2
|
|
Clinical Response-by Sex
Délai: From enrollment to Year 2
|
Clinical Response is defined by the Eckardt score (a 4-item self-report scale measuring weight loss, chest pain, regurgitation, and dysphagia) with no need for retreatment in 2 years. |
From enrollment to Year 2
|
|
Clinical Response-by Race
Délai: From Enrollment to Year 2
|
Clinical Response is defined by the Eckardt score (a 4-item self-report scale measuring weight loss, chest pain, regurgitation, and dysphagia) with no need for retreatment in 2 years. |
From Enrollment to Year 2
|
|
Clinical Response-by Ethnicity
Délai: From Enrollment to Year 2
|
Clinical Response is defined by the Eckardt score (a 4-item self-report scale measuring weight loss, chest pain, regurgitation, and dysphagia) with no need for retreatment in 2 years. |
From Enrollment to Year 2
|
Collaborateurs et enquêteurs
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- PREMEDIA (Pro00083748) - 01
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Type d'informations de prise en charge du partage d'IPD
- PROTOCOLE D'ÉTUDE
- SÈVE
- RSE
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .